Personal Continuous Glucose Monitoring Use Among Adults with Type 2 Diabetes: Clinical Efficacy and Economic Impacts-Reference-Cited by-同舟云学术

Personal Continuous Glucose Monitoring Use Among Adults with Type 2 Diabetes: Clinical Efficacy and Economic Impacts

Published:2021-11 Issue:11 Volume:21 Page:
ISSN:1534-4827
Container-title:Current Diabetes Reports
language:en
Short-container-title:Curr Diab Rep

Author:

Oser Tamara K.^ORCID,Litchman Michelle L.^ORCID,Allen Nancy A.^ORCID,Kwan Bethany M.^ORCID,Fisher Lawrence^ORCID,Jortberg Bonnie T.^ORCID,Polonsky William H.^ORCID,Oser Sean M.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://link.springer.com/content/pdf/10.1007/s11892-021-01408-1.pdf

Reference36 articles.

1. •• American Diabetes Association. Diabetes technology: standards of medical care in diabetes—2021. Diabetes Care. 2021;44(Suppl 1):S85–99. https://doi.org/10.2337/dc21-S007. The most current (2021) ADA Standards regarding technology use in diabetes, including CGM, and thorough consideration of evidence.

2. American Diabetes Association. Diabetes technology: standards of medical care in diabetes—2020. Diabetes Care. 2020;43(Suppl 1):S77–88. https://doi.org/10.2337/dc20-S007.

3. •• Garber AJ, Handelsman Y, Grunberger G, Einhorn D, Abramson MJ, Barzillay JI, Blonde L, Bush MA, DeFronzo RA, Garber JR, Garvey WT, Hirsch IB, Jellinger JS, McGill JB, Mechanick JI, Perreault L, Rosenblit PD, Samson S, Umpierrez GE. Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm—2020 executive summary. Endocr Pract. 2020;26(1):107–39. https://doi.org/10.4158/CS-2019-0472. The most current (2020) AACE/ACE statement on type 2 diabetes management, including preferred use of CGM over SMBG and reasons for this preference.

4. • Beck RW, Riddlesworth TD, Ruedy K, Ahmann A, Haller S, Kruger D, McGill JB, Polonsky W, Price D, Aronoff S, Aronson R. Continuous glucose monitoring versus usual care in patients with type 2 diabetes receiving multiple daily insulin injections: a randomized trial. Ann Intern Med. 2017;167(6):365–74. https://doi.org/10.7326/M16-2855. RCT demonstrating greater HbA1c decrease in rtCGM than SMBG, with additional benefits in mean glucose, TIR, and TAR.

5. • Haak T, Hanaire H, Ajjan R, Hermanns N, Riveline JP, Rayman G. Flash glucose-sensing technology as a replacement for blood glucose monitoring for the management of insulin-treated type 2 diabetes: a multicenter, open-label randomized controlled trial. Diabetes Ther. 2017;8(1):55–73. https://doi.org/10.1007/s13300-016-0223-6. RCT demonstrating substantial decreases in hypoglycemia in adults with T2D treated with IIT.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating the Impact of Continuous Glucose Monitoring on Erectile Dysfunction in Type 1 Diabetes: A Focus on Reducing Glucose Variability and Inflammation;Healthcare;2024-09-12

2. Preparation of a hydrolyzed yeast β-glucan chromium(III) complex and evaluation of its hypoglycemic activity and sub-acute toxicity;International Journal of Biological Macromolecules;2024-08

3. Continuous glucose monitoring among nurse practitioners in primary care: Characteristics associated with prescribing and resources needed to support use;Journal of the American Association of Nurse Practitioners;2024-07-24

4. Cutting-edge technology in medicine: the use of continuous glucose monitoring in reimbursed carein the Czech Republic in 2014-2021: data from the National Registry of Covered Health Services;Vnitřní lékařství;2024-04-10

5. Mixed methods study on the feasibility of implementing periodic continuous glucose monitoring among individuals with type 2 diabetes mellitus in a primary care setting;Heliyon;2024-04